Article Information
- October 4, 2024.
Article Versions
- Version 1 (September 23, 2024 - 09:10).
- You are viewing Version 2, the most recent version of this article.
REVISION SUMMARY
Funding Statement: This work was funded by the VP&S Student Research.
Conflicts of Interest: G.A.M. reports funding from Genentech Roche, Merck, Plexxikon, Regeneron, and BioLineRx, consulting fees for Arcus Bioscience, BioLineRx, and Ipsen, and advisory board member for Pfizer, Revolution Medicine, and CEND Pharm. Consultant for EnGeneIC Inc.
Data Sharing: This study is not a clinical trial.
Ethics Statement: Ethical approval for human subjects research was provided by the Columbia University IRB for this work (IRB#AAAD4969).
AI-Assisted Technologies: No AI-assisted technologies were used to produce any drafts of this manuscript.
Latest version of manuscript including edits for clarity, inclusion of supplementary materials and data, and addition of Figure 1A for depiction of workflow.
Author Information
- Samantha M. Lai, BA*,1,
- Alysala M. Malik, BA1,
- Tejas S. Sathe, MD2,
- Caitlin J. Silvestri, MD2,
- Gulam A. Manji, MD, PhD3 and
- Michael D. Kluger, MD, MPH4
- 1Columbia University Vagelos College of Physicians and Surgeons
- 2Department of Surgery, Columbia University Irving Medical Center
- 3Division of Hematology and Oncology and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
- 4Division of GI and Endocrine Surgery, Columbia University Irving Medical Center
- ↵*Corresponding Author and Reprint Requests: sl5033{at}cumc.columbia.edu